A Multinational, Multicenter Study to Assess the Effects of Oral Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension (PAH)
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2016
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms AFFILIATE
- Sponsors Pfizer
- 02 Dec 2015 Planned primary completion date changed from 1 May 2022 to 1 Sep 2018 as reported by ClinicalTrials.gov
- 07 Oct 2014 Planned End Date changed from 1 Jul 2022 to 1 Jun 2022, according to ClinicalTrials.gov record.
- 07 Oct 2014 Planned primary completion date changed from 1 Jul 2022 to 1 May 2022, according to ClinicalTrials.gov record.